YNYulia Niyazova

Yulia Niyazova

*This is an algorithmically generated author record based on publicly available information.

Yulia Niyazova has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The need to optimize the assessment of medical students’ final knowledge using Artificial intelligence

    by Xeniya Mkhitaryan, Yelena Salikhova, Victor Riklefs, Saule Mussabekova, Yulia Niyazova, Yelena Mukhametova, Bakhyt Suleymenova, Kymbat Zhienbayeva, Irina Baryshnikova

    The Karaganda Medical University has modernized the system for assessing students' final knowledge in the context of modular learning. Testing with one correct answer has been replaced by a system that provides written answers on the session.qmu.kz platform.The platform includes a plagiarism check using the Strikeplagiarizm system. Assessment is carried out according to checklists, including the ability to comment by the examiner. The aim of this study is to optimize the system for assessing students' final knowledge.Methods. The study was conducted among teachers and students of the Karaganda Medical University. The sample of students included 358 people from 1st to 5th years who passed exams on the session.qmu.kz platform in the 2022-2023 academic year.Results. The study identified challenges related to the evaluation of examination papers by faculty and highlighted students’ concerns regarding assessment fairness and examiner feedback. These findings support the need for the implementation of artificial intelligence technologies to improve the analysis of responses, the design of examination questions, and the overall evaluation process.Conclusions. The implementation of an artificial intelligence system in the assessment of the final knowledge of students at medical universities will significantly increase the objectivity of assessments and improve the quality of examination questions, ultimately optimizing the learning process.

  • Membrane serotonin transporter as a Biomarker of Pulmonary arterial hypertension in children with Congenital Heart Defect

    by F. Mindubayeva, Y. Niyazova, R. Nigmatullina, D. Sadykova, L. Akhmaltdinova, Y. Salikhova, I. Kadyrova, M Akhmetova, D. Sabirova

    18 young children (aged from 1 month old to 2 years old) with congenital heart disease were observed. During observation they were divided into 2 groups. Group I-8 children with CHD, not complicated by PAH. Group II 11 children with CHD, complicated by PAH. The content of serotonin and its transporter in platelets, the amount of serotonin in serum were determined. Serotonin content was determined by enzyme-linked immunosorbent assay. The study was performed using the Serotonin ELISA diagnostic kit, IBL Hamburg on the Evolis automated robotic station (BioRad). To determine the Sodium-Dependent serotonin transporter (SLC6A4) there was used the method of quantitative sandwich ELISA of Cusabio production. The main initiator of the development of PAH is development of endothelial dysfunction of the pulmonary vessels. Since the cause of this dysfunction is associated with functional disorders of the serotonergic system, our task was to determine the content of SERT and serotonin in platelets in the studied groups. We suggest that the serotonin transporter (SERT), which is responsible for the proliferation of the pulmonary artery smooth-muscle cells (PASMC), can be used as a biomarker for predicting and diagnosing PAH in children with CHD. The need for early biomarkers in the diagnosis of PAH in children is claimed by scientists from many countries of the world [1, 2]. The results of our studies showed a significant increase in the concentration of SERT in platelets in group II, compared with group I more than several times. The serotonin content in platelets in children of group II tended to decrease as compared with group I. Perhaps, an excessive increase in transporters in platelets is sufficient in itself for the induction of PASMC hyperplasia and the subsequent development of PAH. It is necessary to continue research in this direction, which will help to reveal and understand the molecular mechanisms by which SERT regulates the proliferation of PASMC and the role of serotonin and its transporter in the development of PAH in children.